SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-24-213396
Filing Date
2024-09-05
Accepted
2024-09-04 20:56:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 F-3 d867638df3.htm F-3 467079
2 EX-1.3 d867638dex13.htm EX-1.3 26366
3 EX-5.1 d867638dex51.htm EX-5.1 61203
4 EX-23.2 d867638dex232.htm EX-23.2 2226
5 EX-23.3 d867638dex233.htm EX-23.3 2064
6 EX-FILING FEES d867638dexfilingfees.htm EX-FILING FEES 59265
7 GRAPHIC g867638g0624075929743.jpg GRAPHIC 3107
8 GRAPHIC g867638g0624075929969.jpg GRAPHIC 7125
9 GRAPHIC g867638g0904204824561.jpg GRAPHIC 3107
10 GRAPHIC g867638g58f53.jpg GRAPHIC 24453
  Complete submission text file 0001193125-24-213396.txt   672082
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-3 | Act: 33 | File No.: 333-281937 | Film No.: 241279542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)